Oncological outcomes of unsuspected pN2 in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Michiel A IJsseldijkRichard Peter Gerardus Ten BroekBastiaan WieringEdo HekmaMarnix A J de RoosPublished in: Interactive cardiovascular and thoracic surgery (2021)
In patients with cN0-1 NSCLC, a minority has unsuspected pN2 NSCLC. Even for these patients, 5-year OS and disease-free survival are reasonable. VATS with adequate lymph node dissection is the treatment of choice when in experienced hands. Adjuvant therapy should be provided in absence of relevant comorbidity.
Keyphrases
- free survival
- small cell lung cancer
- end stage renal disease
- rectal cancer
- newly diagnosed
- ejection fraction
- chronic kidney disease
- advanced non small cell lung cancer
- radical prostatectomy
- robot assisted
- prostate cancer
- lymph node
- metabolic syndrome
- radiation therapy
- brain metastases
- sentinel lymph node
- early stage
- combination therapy
- weight loss